Biopharma Company Alvotech to Go Public in $2.25 Bln SPAC Deal

Biopharmaceutical company Alvotech Holdings SA said on Tuesday it plans to list in New York by merging with a blank-check company backed by Oaktree Capital Management, in a deal that values the combined entity at around $2.25 billion. Read More